Vitamin D Level and Its Relation to Pre-eclampsia and Eclampsia
NCT ID: NCT03882099
Last Updated: 2019-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2019-03-17
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between Maternal Vitamin D Level And Preterm Birth
NCT03638037
Vitamin D in Ectopic Pregnancies
NCT03894735
Prevalence of Vitamin D Deficiency in Pregnant Women and Their Fetus in North Jordan
NCT04944212
Effect of Vitamin D Intake in Pregnancy to Prevent Recurrence of Gestational Diabetes
NCT03701087
Vitamin D and Hypertensive Disorders of Pregnancy
NCT07017920
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Preeclampsia is defined as systolic BP \>140 and/or diastolic BP\>90 on two occasions, 4 hours apart in pregnant females\>20 weeks, plus proteinuria \>/= 1+ urine dipstick protein.
* Eclampsia defined as tonic-clonic seizures in women with pre-eclampsia.
* Controls are normotensive pregnant females with no proteinuria and no other medical disorders.
* The determination of 25(OH) D is based on a competitive enzyme-linked immunosorbant assay (ELISA) using the 25(OH)D3/D2 ELISA system (ORGENTIC DIAGNOSTIKA GmbH, Germany)
Inclusion criteria:
Age 20-35 years Gestational age 30-40 weeks
Exclsion criteria:
Twin pregnancy Other medical conditions during prrgnancy Drugs that influence Vit D levels eg.antiepileptics and antituberculous treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women with pre-eclampsia
Determination of Vitamin D by ELISA
Blood samples
Pregnant women with eclampsia
Determination of Vitamin D by ELISA
Blood samples
Normotensive pregnant women
Determination of Vitamin D by ELISA
Blood samples
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Determination of Vitamin D by ELISA
Blood samples
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age 30-40 weeks
Exclusion Criteria
* Other medical conditions during pregnancy
* Drugs that influence Vit D levels eg.antiepileptics and antituberculous treatment
20 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yahia El-Faissal
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
173019OBGYN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.